BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38222120)

  • 21. Retinal fluid changes and therapeutic effects in symptomatic circumscribed choroidal hemangioma patients: a long-term follow up study.
    Lee J; Lee CS; Kim M; Lee SC
    BMC Ophthalmol; 2018 Dec; 18(1):321. PubMed ID: 30545324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circumscribed Choroidal Hemangioma: Visual Outcome in the Pre-Photodynamic Therapy Era versus Photodynamic Therapy Era in 458 Cases.
    Shields CL; Dalvin LA; Lim LS; Chang M; Udyaver S; Mazloumi M; Vichitvejpaisal P; Su GL; Florakis E; Mashayekhi A; Shields JA
    Ophthalmol Retina; 2020 Jan; 4(1):100-110. PubMed ID: 31611094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Photodynamic therapy for choroidal hemangioma unresponsive to ranibizumab.
    Chan LW; Hsieh YT
    Optom Vis Sci; 2014 Sep; 91(9):e226-9. PubMed ID: 25036544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Standard versus bolus photodynamic therapy in circumscribed choroidal hemangioma: functional outcomes.
    Pilotto E; Urban F; Parrozzani R; Midena E
    Eur J Ophthalmol; 2011; 21(4):452-8. PubMed ID: 21279975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Photodynamic therapy in the management of circumscribed choroidal hemangioma.
    Elizalde J; Vasquez L; Iyo F; Abengoechea S
    Can J Ophthalmol; 2012 Feb; 47(1):16-20. PubMed ID: 22333845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Photodynamic therapy with double duration for circumscribed choroidal haemangioma: functional and anatomical results based on initial parameters.
    Süsskind D; Inhoffen W; Gelisken F; Völker M
    Clin Exp Ophthalmol; 2018 Jul; 46(5):495-501. PubMed ID: 29131474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combination facula photodynamic therapy for circumscribed choroidal hemangioma].
    Su ZA; Shen J; Yao K; Zhang LX; Teng Y
    Zhonghua Yan Ke Za Zhi; 2008 Sep; 44(9):790-3. PubMed ID: 19175157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COMPARATIVE EFFECTIVENESS OF PROTON BEAM VERSUS PHOTODYNAMIC THERAPY TO SPARE THE VISION IN CIRCUMSCRIBED CHOROIDAL HEMANGIOMA.
    Mathis T; Maschi C; Mosci C; Espensen CA; Rosier L; Favard C; Tick S; Remignon CH; Ligorio P; Bonin N; Gambrelle J; Nguyen AM; Faber C; Meyer L; Mouriaux F; Herault J; Baillif S; Kiilgaard JF; Kodjikian L; Caujolle JP; Salleron J; Thariat J
    Retina; 2021 Feb; 41(2):277-286. PubMed ID: 32404844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic effect of modified double-dose photodynamic therapy in circumscribed choroidal haemangioma.
    Byeon HJ; Lee JH; Lee J; Choi EY; Kim YJ; Lee SC; Lee CS
    Br J Ophthalmol; 2023 Mar; 107(3):425-429. PubMed ID: 34580074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Half-Dose Photodynamic Therapy as a Novel Treatment Protocol for Circumscribed Choroidal Hemangioma.
    Pérez-González D; Goldstein M; Iglicki M; Zur D
    Life (Basel); 2022 Oct; 12(11):. PubMed ID: 36362903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of the standard photodynamic treatment protocol for symptomatic circumscribed choroidal hemangioma.
    Vicuna-Kojchen J; Banin E; Averbukh E; Barzel I; Shulman M; Hemo I; Pe'er J; Chowers I
    Ophthalmologica; 2006; 220(6):351-5. PubMed ID: 17095878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DOUBLE FLUENCE PHOTODYNAMIC THERAPY FOR THE TREATMENT OF CIRCUMSCRIBED CHOROIDAL HEMANGIOMA.
    Pellegrini M; Staurenghi G; Mambretti M; Preziosa C
    Retina; 2022 Apr; 42(4):767-774. PubMed ID: 34861659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circumscribed choroidal hemangioma: clinical manifestations and factors predictive of visual outcome in 200 consecutive cases.
    Shields CL; Honavar SG; Shields JA; Cater J; Demirci H
    Ophthalmology; 2001 Dec; 108(12):2237-48. PubMed ID: 11733265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of outcomes between overlapping-spot and single-spot photodynamic therapy for circumscribed choroidal hemangioma.
    Su ZA; Tang XJ; Zhang LX; Su XH
    Int J Ophthalmol; 2014; 7(1):66-70. PubMed ID: 24634866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.
    Chan WM; Lam DS; Lai TY; Liu DT; Li KK; Yao Y; Wong TH
    Ophthalmology; 2004 Aug; 111(8):1576-84. PubMed ID: 15288991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photodynamic therapy for bullous retinal detachment: a single-center experience of case series with a 6-month follow-up study.
    Gao T; Qu J; Xiao J; Hu J; Zhao M
    Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1429-1439. PubMed ID: 29869216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term efficacy and safety of verteporfin photodynamic therapy in combination with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy.
    Jain P; Anantharaman G; Gopalakrishnan M; Goyal A
    Indian J Ophthalmol; 2018 Aug; 66(8):1119-1127. PubMed ID: 30038155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long term results of photodynamic therapy in intraocular tumors.
    Karaca BÖ; Türkoğlu EB; Doğan ME
    Photodiagnosis Photodyn Ther; 2023 Jun; 42():103564. PubMed ID: 37031899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding the structural changes following photodynamic and transpupillary thermotherapy for choroidal hemangioma using optical coherence tomography and optical coherence tomography angiography.
    Raval V; Tyagi M; Chhablani J; Kaliki S; Reddy R; Das T
    Indian J Ophthalmol; 2019 Dec; 67(12):2023-2028. PubMed ID: 31755443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Polypoidal choroidal vasculopathy].
    Yuzawa M
    Nippon Ganka Gakkai Zasshi; 2012 Mar; 116(3):200-31; discussion 232. PubMed ID: 22568102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.